100k shorts yesterday on trading a little over 300k at a guess (280k ASX plus ? Cboe)
They have $30m cash so there's no financial stress from any likely CR, so I guess the issue is
The FDA has reviewed AROA’s 510(k) application for Myriad Flow™, a new soft tissue
regeneration product that could be commercialised in combination with Enivo™, and requested
additional pre-clinical and clinical data to support a clearance. Both studies appear to be less
complex than anticipated with regulatory clearances expected within 24 months.
and
AROA is updating its FY24 full-year guidance for total revenue, product revenue, product gross margin
and a normalised EBITDA loss to NZ$67-70 million, NZ$66-69 million, 85% and NZ$1-3 million
respectively.2 Previous guidance (published on 28 November 2023) was in the range of NZ$73-76
million, NZ$72-75 million, 85% and NZ$1-2 million [profit]
Slippage! A 12 month delay to profitability.
Come on finish 1.60 plus, page-437
-
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ARX (ASX) to my watchlist
|
|||||
Last
44.0¢ |
Change
-0.065(12.9%) |
Mkt cap ! $151.4M |
Open | High | Low | Value | Volume |
50.0¢ | 50.0¢ | 44.0¢ | $2.259M | 4.988M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 12699 | 44.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
46.0¢ | 1954 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 12699 | 0.440 |
9 | 55823 | 0.435 |
5 | 527340 | 0.430 |
1 | 1500 | 0.425 |
1 | 500 | 0.420 |
Price($) | Vol. | No. |
---|---|---|
0.460 | 1954 | 1 |
0.465 | 77000 | 2 |
0.500 | 5462 | 3 |
0.510 | 155000 | 1 |
0.520 | 47035 | 2 |
Last trade - 16.10pm 22/08/2024 (20 minute delay) ? |
Featured News
ARX (ASX) Chart |
The Watchlist
SS1
SUN SILVER LIMITED
Gerard O'Donovan, Executive Director
Gerard O'Donovan
Executive Director
SPONSORED BY The Market Online